Orchard Therapeutics PLC ORTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 4:00 PM EST
0.446quote price arrow up+0.001 (+0.2247%)
Volume
165,914
52 week range
0.41 - 1.55
Loading...
  • Open0.446
  • Day High0.4499
  • Day Low0.44
  • Prev Close0.445
  • 52 Week High1.55
  • 52 Week High Date01/03/22
  • 52 Week Low0.41
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap56.504M
  • Shares Out126.69M
  • 10 Day Average Volume0.18M
  • Dividend-
  • Dividend Yield-
  • Beta0.66
  • YTD % Change-66.21

KEY STATS

  • Open0.446
  • Day High0.4499
  • Day Low0.44
  • Prev Close0.445
  • 52 Week High1.55
  • 52 Week High Date01/03/22
  • 52 Week Low0.41
  • 52 Week Low Date05/12/22
  • Market Cap56.504M
  • Shares Out126.69M
  • 10 Day Average Volume0.18M
  • Dividend-
  • Dividend Yield-
  • Beta0.66
  • YTD % Change-66.21

RATIOS/PROFITABILITY

  • EPS (TTM)-1.40
  • P/E (TTM)-0.32
  • Fwd P/E (NTM)-0.57
  • EBITDA (TTM)-129.215M
  • ROE (TTM)-98.15%
  • Revenue (TTM)16.152M
  • Gross Margin (TTM)73.14%
  • Net Margin (TTM)-1,109.00%
  • Debt To Equity (MRQ)26.78%

EVENTS

  • Earnings Date03/10/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Orchard Therapeutics PLC

 

Profile

MORE
Orchard Therapeutics plc is a gene therapy company. The Company is engaged in development, manufacturing and commercialization of gene and cell therapies to provide curative therapies to patients suffering from a range of diseases. The Company's portfolio includes a commercial-stage product and research and development-stage product candidates. It is focused on severe neurometabolic diseases and early research programs in rare primary immune deficiencies, including OTL-103...
James Geraghty J.D.
Non-Executive Independent Chairman of the Board
Bobby Gaspar M.D., Ph.D.
Chief Executive Officer, Director
Frank Thomas
President, Chief Operating Officer
Address
245 Hammersmith Road, 3Rd Floor
London
W6 8PW
United Kingdom

Top Peers

SYMBOLLASTCHG%CHG
ISO
IsoPlexis Corp
1.42-0.07-4.38%
TCRX
TScan Therapeutics Inc
2.10-0.21-8.87%
LPCN
Lipocine Inc
0.4376-0.0191-4.1822%
HOOK
HOOKIPA Pharma Inc
1.04+0.04+4.00%
SLDB
Solid Biosciences Inc
6.58-0.06-0.90%